Today: 26 June 2026

Khadija Saeed

Khadija Saeed is a financial markets reporter at TS2.tech, specializing in stocks, technology and emerging industries. She studied economics and finance at the London School of Economics and previously worked in market research before moving into financial journalism. Her coverage focuses on the companies, innovations and economic trends influencing global investors.

Kulicke & Soffa (KLIC) Jumps 11% After Q4 2025 Earnings Beat and Upbeat 2026 Guidance

Kulicke & Soffa (KLIC) Jumps 11% After Q4 2025 Earnings Beat and Upbeat 2026 Guidance

KLIC shares jumped 11% to around $39.23 Thursday after Kulicke & Soffa posted better-than-expected Q4 earnings and raised its outlook for early fiscal 2026. Volume neared 900,000 shares by early afternoon. Q4 revenue reached $177.6 million, down 2% year over year but up 20% sequentially. The move follows a 12% after-hours surge Wednesday after the company beat Wall Street estimates.
20 November 2025
1 873 874 875

Stock Market Today

  • PNC Financial to Raise Dividend by 18% Following 2026 Fed Stress Test Success
    June 26, 2026, 1:09 PM EDT. PNC Financial Services plans an 18% increase in its quarterly dividend to $2 per share after passing the 2026 Federal Reserve stress test, confirming its robust capital position. The bank's Common Equity Tier 1 (CET1) ratio stands at 10.1%, well above the required 7%. PNC's stress capital buffer remains at the minimum 2.5% until October 2027 amid ongoing Fed supervisory reviews. The proposed dividend hike awaits board approval on July 6, 2026, and reflects confidence in continued earnings and liquidity, supported by $31.7 billion in available liquidity and a share repurchase program. PNC's dividend yield of 2.8% surpasses the industry average, highlighting its strength amid regulatory requirements and market conditions.

Latest News

Moderna (NASDAQ:MRNA) gains $3.3 billion after CAR-T update

Moderna (NASDAQ:MRNA) gains $3.3 billion after CAR-T update

26 June 2026
Moderna soared 13.9% to $68.06 after unveiling mRNA-6007, an in vivo CAR-T candidate for autoimmune disease, at its Science Day, adding $3.3 billion in equity value—more than its 2026 R&D forecast—despite no near-term sales boost, with analysts split on future prospects and cash burn risks.
Netflix (NASDAQ:NFLX) rebound leaves $175 billion Wall Street divide

Netflix (NASDAQ:NFLX) rebound leaves $175 billion Wall Street divide

26 June 2026
Netflix (NASDAQ:NFLX) jumped 5.9% to $75.10 after hitting a 20-month low, but the stock still trades far below the $115.82 average analyst target, leaving a $175 billion equity value gap; with 2027 EPS estimates steady and Q2 results due July 16, investors are watching whether ads and earnings can close the gap.
Go toTop